Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Orgenesis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Orgenesis Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Orgenesis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Orgenesis Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Orgenesis Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Orgenesis Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Orgenesis Raises USD1.2 Million in Venture Financing 12
Orgenesis Raises USD5.3 Million in Financing Round 13
Partnerships 14
Zelluna Immunotherapy Enters into Partnership with Masthercell 14
CRISPR Therapeutics Enters into Agreement with MaSTherCell 15
Les Laboratoires Servier and Masthercell Enter into Agreement 16
Orgenesis Forms Joint Venture with Atvio Biotech 17
Orgenesis Forms Joint Venture with CureCell 18
Orgenesis Enters into Agreement with Biosequel 19
Orgenesis Enters into Research Agreement with GSRAC 20
Masthercell Forms Joint Venture with Kalon 21
Licensing Agreements 22
Orgenesis Enters into Licensing Agreement with Hemogenyx-Cell 22
Orgenesis Enters into Licensing Agreement with Immugenyx 23
HekaBio Enters into Licensing Agreement with Orgenesis 24
Orgenesis Enters into Licensing Agreement with BGN Technologies and National Institute for Biotechnology in the Negev 25
Orgenesis Enters Into Licensing Agreement With Tel Hashomer Medical Research For Autologous Insulin Producing Cells Regeneration Technology 26
Equity Offering 27
Orgenesis Plans to Raise up to USD100 Million in Public Offering of Securities 27
Masthercell Raises USD5.9 Million in Equity Financing 28
Orgenesis Raises USD1 Million in Private Placement of Shares and Warrants 29
Orgenesis Raises USD4.3 Million in Private Placement of Shares and Warrants 30
Orgenesis Raises Funds through Private Placement of Shares and Warrants 31
Orgenesis Raises Funds through Private Placement of Shares and Warrants 32
Orgenesis Raises USD0.2 Million in Private Placement of Shares and Warrants 33
Orgenesis Announces Private Placement Of Shares For US$3 Million 34
Orgenesis Completes Private Placement Of Units For US$1.3 Million 35
Acquisition 36
Orgenesis Acquires MaSTherCell 36
Orgenesis Inc – Key Competitors 37
Orgenesis Inc – Key Employees 38
Orgenesis Inc – Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Recent Developments 40
Financial Announcements 40
Apr 19, 2018: Orgenesis Reports 42% Increase in Revenue for the First Quarter of Fiscal 2018 40
Government and Public Interest 42
Feb 13, 2017: Orgenesis Approved for Euro 12.3 Million European Grant for Further Development of Its Type 1 Diabetes Program 42
Other Significant Developments 43
Mar 08, 2017: Orgenesis Provides Update Regarding AIP Cell-Based Therapy for Type 1 Diabetes, MaSTherCell Cell Manufacturing Subsidiary and Overall Financial Condition 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44
Orgenesis Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Orgenesis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Orgenesis Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Orgenesis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Orgenesis Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Orgenesis Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Orgenesis Raises USD1.2 Million in Venture Financing 12
Orgenesis Raises USD5.3 Million in Financing Round 13
Zelluna Immunotherapy Enters into Partnership with Masthercell 14
CRISPR Therapeutics Enters into Agreement with MaSTherCell 15
Les Laboratoires Servier and Masthercell Enter into Agreement 16
Orgenesis Forms Joint Venture with Atvio Biotech 17
Orgenesis Forms Joint Venture with CureCell 18
Orgenesis Enters into Agreement with Biosequel 19
Orgenesis Enters into Research Agreement with GSRAC 20
Masthercell Forms Joint Venture with Kalon 21
Orgenesis Enters into Licensing Agreement with Hemogenyx-Cell 22
Orgenesis Enters into Licensing Agreement with Immugenyx 23
HekaBio Enters into Licensing Agreement with Orgenesis 24
Orgenesis Enters into Licensing Agreement with BGN Technologies and National Institute for Biotechnology in the Negev 25
Orgenesis Enters Into Licensing Agreement With Tel Hashomer Medical Research For Autologous Insulin Producing Cells Regeneration Technology 26
Orgenesis Plans to Raise up to USD100 Million in Public Offering of Securities 27
Masthercell Raises USD5.9 Million in Equity Financing 28
Orgenesis Raises USD1 Million in Private Placement of Shares and Warrants 29
Orgenesis Raises USD4.3 Million in Private Placement of Shares and Warrants 30
Orgenesis Raises Funds through Private Placement of Shares and Warrants 31
Orgenesis Raises Funds through Private Placement of Shares and Warrants 32
Orgenesis Raises USD0.2 Million in Private Placement of Shares and Warrants 33
Orgenesis Announces Private Placement Of Shares For US$3 Million 34
Orgenesis Completes Private Placement Of Units For US$1.3 Million 35
Orgenesis Acquires MaSTherCell 36
Orgenesis Inc, Key Competitors 37
Orgenesis Inc, Key Employees 38
Orgenesis Inc, Subsidiaries 39
List of Figures
Orgenesis Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Orgenesis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Orgenesis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Orgenesis Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Orgenesis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Orgenesis Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Orgenesis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Orgenesis Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9